Bennett C, Hoosain Z, Koen A, Lalloo U, et al. Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living With and Without HIV-1 Infection: A Phase 2 Randomised Trial. J Infect 2024 Sep 27:106285. doi: 10.1016/j.jinf.2024.106285.
PMID: 39343247